Heteroarylalkanoic acids as integrin receptor antagonists

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4245 (2006.01) A61K 31/4745 (2006.01) A61P 19/02 (2006.01) A61P 19/10 (2006.01) A61P 27/00 (2006.01) A61P 35/00 (2006.01) A61P 35/04 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2507699

The present invention relates to pharmaceutical compositions comprising compounds of the Formula I, or a pharmaceutically acceptable salt thereof, and methods of selectively inhibiting or antagonizing the .alpha..nu..beta.3 and/or the .alpha..nu..beta.5 integrin without significantly inhibiting the .alpha..nu..beta.6 integrin.

La présente invention a trait à des compositions pharmaceutiques comprenant des composés de formule (I), ou un sel pharmaceutiquement acceptable de celui-ci, et des procédés d'inhibition ou d'antagonisation sélective de .alpha.¿v?.beta.¿5? et/ou de l'intégrine .alpha.¿v?.beta.¿5? sans inhibition notable de l'intégrine .alpha.¿v?.beta.¿6?.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heteroarylalkanoic acids as integrin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heteroarylalkanoic acids as integrin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroarylalkanoic acids as integrin receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1963862

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.